viewFeedback PLC

Full interview: Feedback hails new fluoroscopy technology

Feedback (LON:FDBK) specialises in medical imaging technology, such as magnetic resonance imaging (MRI) scans and X-Rays.
CEO Tom Oakley is a radiologist and understands the niche gaps in the medical imaging market and here he tells Proactive London how he's building a new revenue stream on the back of software already developed.
Oakley explains how his company is rolling out the new fluoroscopy technique, which is basically a x-ray movie, across 200 sites in the US 
and how it doesn't mean expensive new kit for users.
Updates here too on Feedback's flagship Bleepa product, the encrypted medical messaging app used on smartphones, tablets and desktops, allowing clinicians to communicate with other team members securely.

Quick facts: Feedback PLC

Price: 1.1 GBX

Market: LSE
Market Cap: £5.94 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Feedback PLC named herein, including the promotion by the Company of Feedback PLC in any Content on the Site, the Company receives from said...



Feedback PLC's Tom Oakley gives clear message to NHS as Bleepa secures CE mark

Feedback PLC's (LON:FDBK) Tom Oakley speaks to Proactive London's Andrew Scott after announcing that Bleepa, its flagship imaging-based medical communications platform, has achieved a CE Mark for Europe. Oakley says Bleepa, which allows clinicians to access medical-grade images through...

5 days, 11 hours ago

2 min read